235 related articles for article (PubMed ID: 25710171)
1. Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
Duong YT; Kassanjee R; Welte A; Morgan M; De A; Dobbs T; Rottinghaus E; Nkengasong J; Curlin ME; Kittinunvorakoon C; Raengsakulrach B; Martin M; Choopanya K; Vanichseni S; Jiang Y; Qiu M; Yu H; Hao Y; Shah N; Le LV; Kim AA; Nguyen TA; Ampofo W; Parekh BS
PLoS One; 2015; 10(2):e0114947. PubMed ID: 25710171
[TBL] [Abstract][Full Text] [Related]
2. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
[TBL] [Abstract][Full Text] [Related]
3. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
[TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
[TBL] [Abstract][Full Text] [Related]
5. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
[TBL] [Abstract][Full Text] [Related]
6. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
[TBL] [Abstract][Full Text] [Related]
7. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
[TBL] [Abstract][Full Text] [Related]
8. Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence.
Gao Z; Yan H; Feng X; Wu L; Qiu M; Xing W; Zhang G; Zhang Z; Jiang Y
PLoS One; 2016; 11(8):e0161183. PubMed ID: 27513563
[TBL] [Abstract][Full Text] [Related]
9. Short Communication: Heightened HIV Antibody Responses in Postpartum Women as Exemplified by Recent Infection Assays: Implications for Incidence Estimates.
Hargrove JW; van Schalkwyk C; Humphrey JH; Mutasa K; Ntozini R; Owen SM; Masciotra S; Parekh BS; Duong YT; Dobbs T; Kilmarx PH; Gonese E
AIDS Res Hum Retroviruses; 2017 Sep; 33(9):902-904. PubMed ID: 28443672
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
[TBL] [Abstract][Full Text] [Related]
11. Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein.
Wei X; Liu X; Dobbs T; Kuehl D; Nkengasong JN; Hu DJ; Parekh BS
AIDS Res Hum Retroviruses; 2010 Jan; 26(1):61-71. PubMed ID: 20063992
[TBL] [Abstract][Full Text] [Related]
12. Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.
Serhir B; Hamel D; Doualla-Bell F; Routy JP; Beaulac SN; Legault M; Fauvel M; Tremblay C;
PLoS One; 2016; 11(5):e0156023. PubMed ID: 27224023
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
[TBL] [Abstract][Full Text] [Related]
14. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
Sempa JB; Welte A; Busch MP; Hall J; Hampton D; Facente SN; Keating SM; Marson K; Parkin N; Pilcher CD; Murphy G; Grebe E;
PLoS One; 2019; 14(7):e0220345. PubMed ID: 31348809
[TBL] [Abstract][Full Text] [Related]
15. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
[TBL] [Abstract][Full Text] [Related]
16. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
Parekh BS; Hanson DL; Hargrove J; Branson B; Green T; Dobbs T; Constantine N; Overbaugh J; McDougal JS
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):265-73. PubMed ID: 20954834
[TBL] [Abstract][Full Text] [Related]
17. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.
Parekh BS; Hu DJ; Vanichseni S; Satten GA; Candal D; Young NL; Kitayaporn D; Srisuwanvilai LO; Rakhtam S; Janssen R; Choopanya K; Mastro TD
AIDS Res Hum Retroviruses; 2001 Mar; 17(5):453-8. PubMed ID: 11282014
[TBL] [Abstract][Full Text] [Related]
19. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.
Parekh BS; Kennedy MS; Dobbs T; Pau CP; Byers R; Green T; Hu DJ; Vanichseni S; Young NL; Choopanya K; Mastro TD; McDougal JS
AIDS Res Hum Retroviruses; 2002 Mar; 18(4):295-307. PubMed ID: 11860677
[TBL] [Abstract][Full Text] [Related]
20. Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
Keating SM; Rountree W; Grebe E; Pappas AL; Stone M; Hampton D; Todd CA; Poniewierski MS; Sanchez A; Porth CG; Denny TN; Busch MP;
PLoS One; 2019; 14(9):e0222290. PubMed ID: 31525218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
